Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Abliva

Less than 1K followers
All
Webcasts
Press releases
3rd party
ShowingAll content types

Press release2025-03-17 12:05

BioStock: Sista handelsdag för Abliva - bolaget lämnar Nasdaq Stockholm

Abliva
Press release2025-03-17 12:05

BioStock: Last trading day for Abliva - the company leaves Nasdaq Stockholm

Abliva
Regulatory press release2025-03-03 13:10

Avnotering av aktierna i Abliva: sista handelsdag 17 mars 2025

Abliva

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
Followings and notifications on followed companies
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release2025-03-03 13:10

Delisting of the shares of Abliva: last day of trading 17 March 2025

Abliva
Regulatory press release2025-02-26 08:30

Kallelse till extra bolagsstämma i Abliva AB (publ)

Abliva
Regulatory press release2025-02-26 08:30

Notice of Extraordinary General Meeting in Abliva AB (publ)

Abliva
Regulatory press release2025-02-25 09:50

Abliva ansöker om avnotering och kommer att kalla till extra bolagsstämma

Abliva
Regulatory press release2025-02-25 09:50

Abliva applies for delisting and will convene an extraordinary general meeting

Abliva
Press release2025-02-24 17:30

Penser Access & Future by Carnegie: Abliva: Uppköpsprocessen nästan färdigställd

Abliva
Regulatory press release2025-02-21 14:40

Finansinspektionen: Flaggningsmeddelande i Abliva AB

Abliva
Press release2025-02-21 08:42

BioStock: Pharming Technologies avslutar Abliva-affären - tvångsinlösen inledd

Abliva
Regulatory press release2025-02-21 08:30

Abliva AB Bokslutskommuniké januari – december 2024

Abliva
Regulatory press release2025-02-21 08:30

Abliva AB Year-End Report January – December 2024

Abliva
Regulatory press release2025-02-12 11:36

Finansinspektionen: Flaggningsmeddelande i Abliva AB

Abliva
Regulatory press release2025-02-11 15:51

Finansinspektionen: Flaggningsmeddelande i Abliva AB

Abliva
Press release2025-02-10 10:43

BioStock: Pharming fullföljer bud på Abliva

Abliva
Press release2025-02-10 10:43

BioStock: Pharming completes bid for Abliva

Abliva
Press release2024-12-16 08:00

Penser Access & Future by Carnegie: Abliva: Uppköpserbjudande från Pharming

Abliva
Regulatory press release2024-12-15 20:00

Uttalande från Ablivas styrelse med anledning av Pharmings kontanta offentliga uppköpserbjudande

Abliva
Regulatory press release2024-12-15 20:00

Statement by the Board of Directors of Abliva regarding the public cash offer from Pharming

Abliva